Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical science

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/CS20110272PMID 22264240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer immunology.

  2011cited by this paper
• A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood–derived mononuclear cells by a simple two‐step culture method

  2010cited by this paper
• De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination.

  2009cited by this paper
• De Novo T-Lymphocyte Responses against Baculovirus-derived Recombinant Influenzavirus Hemagglutinin Generated by a Naive Umbilical Cord Blood Model of Dendritic Cell Vaccination

  2008cited by this paper
• Induction of Proliferation and Monocytic Differentiation of Human CD34+ Cells by CD137 Ligand Signaling

  2008cited by this paper
• Cancer Immunology

  2008cited by this paper
• Ex Vivo Expansion Does Not Alter the Capacity of Umbilical Cord Blood CD34+ Cells to Generate Functional T Lymphocytes and Dendritic Cells

  2006cited by this paper
• Dendritic Cell-Based Immunotherapy

  2006cited by this paper
• DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMAS: CURRENT STATUS AND FUTURE DIRECTIONS

  2006cited by this paper
• In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes.

  2006cited by this paper
• Recent advances in immunotherapy for human glioma

  2006cited by this paper
• Dendritic cells as therapeutic vaccines against cancer

  2005cited by this paper
• Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood.

  2005cited by this paper
• Induction of human papillomavirus type 16‐specific immunologic responses in a normal and an human papillomavirus‐infected populations

  2005cited by this paper
• CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination

  2003cited by this paper
• Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo

  2002cited by this paper
• Cytokines in the generation and maturation of dendritic cells: recent advances.

  2002cited by this paper
• Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome

  2002cited by this paper
• Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

  2002cited by this paper
• Progress in cancer vaccines by enhanced self-presentation

  2001cited by this paper
• Identification of both myeloid CD11c+ and lymphoid CD11c− dendritic cell subsets in cord blood

  2001cited by this paper
• Dendritic cells as vectors for therapy.

  2001cited by this paper
• Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

  2001cited by this paper
• Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune Responses1

  2000cited by this paper
• Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.

  2000cited by this paper
• CpG-DNA Activates In Vivo T Cell Epitope Presenting Dendritic Cells to Trigger Protective Antiviral Cytotoxic T Cell Responses1

  2000cited by this paper
• Generation of Interferon α–Producing Predendritic Cell (Pre-Dc)2 from Human Cd34+ Hematopoietic Stem Cells

  2000cited by this paper
• In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

  2000cited by this paper
• Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

  1999cited by this paper
• Isolation of broadly reactive, tumor-specific, HLA Class-I restricted CTL from blood lymphocytes of a breast cancer patient.

  1999cited by this paper
• Interleukin-6 Inhibits Transforming Growth Factor-β-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt and Signal Transducers and Activators of Transcription 3 Pathways*

  1999cited by this paper
• Identification of cord blood dendritic cells as an immature CD11c- population.

  1999cited by this paper
• Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor.

  1999cited by this paper
• Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

  1998cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1997cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1996cited by this paper
• Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

  1995cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper

• Αn optimized, simplified and clinically approved culture system to produce, in large scale, dendritic cells capable of priming specific T cells.

  2022cites this paper
• Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.

  2019cites this paper
• Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model.

  2019cites this paper
• Anti-cancer potency and mechanism of human umbilical cord blood stem cell

  2019cites this paper
• Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization

  2019cites this paper
• A method for the generation of large numbers of dendritic cells from CD34+ hematopoietic stem cells from cord blood

  2019cites this paper
• Trop2 Guarantees Cardioprotective Effects of Cortical Bone-Derived Stem Cells on Myocardial Ischemia/Reperfusion Injury

  2018cites this paper
• Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution.

  2016cites this paper
• Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.

  2016cites this paper
• Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.

  2015cites this paper
• Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK 1 / 2 phosphorylation and p 38 dephosphorylation

  2015cites this paper
• Umbilical cord blood-derived CD 11 c + dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

  2015cites this paper
• Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

  2015cites this paper